News & Events

Washington University School of Medicine in St. Louis has received two large grants renewing funding for the Human Pangenome Reference Sequencing Project. This ambitious program began in 2019 with the goal of increasing the diversity of human genome sequences that are pooled into the widely used reference genome. A thorough representation of human genetic diversity can help researchers discover how genetic variation contributes to disease and perhaps offer new routes to innovative treatments.

Yung-Chun (David) Wang, PhD, an instructor in the Jin lab was recently awarded the Center of Regenerative Medicine’s hCTO microgrant. This microgrant will support his research into congenital hydrocephalus (CH), a developmental brain disorder characterized by abnormal cerebrospinal fluid accumulation.

Researchers at WashU Medicine have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy. The strategy, which they demonstrated in cells in the lab, forces brain cancer cells to display targets for the immune system to attack.

Dr. Sheng Chih (Peter) Jin, has received a $3.2 million grant from the National Institutes of Health (NIH) to study the genetic and molecular underpinnings of congenital hydrocephalus.

Dr. Joseph Corbo, Dr. Michael White from Washington University in St. Louis along with a team at the University of Porto in Portugal describe that a single enzyme appears to be responsible for toggling a parrot’s pigments from red to yellow.